Smoking cessation and bupropion: predictive factors of success therapy

I. Sampablo, C. K. Felipe, L. J. Lores, C. Dolors, M. Josep (Barcelona, Sant Boi, Badalona, Spain)

Source: Annual Congress 2003 - Smoking cessation
Session: Smoking cessation
Session type: Oral Presentation
Number: 1087
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Sampablo, C. K. Felipe, L. J. Lores, C. Dolors, M. Josep (Barcelona, Sant Boi, Badalona, Spain). Smoking cessation and bupropion: predictive factors of success therapy. Eur Respir J 2003; 22: Suppl. 45, 1087

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Zyban and smoking cessation: predictors of success
Source: Eur Respir J 2003; 22: Suppl. 45, 126s
Year: 2003

Success rates of smoking cessation program using bupropion therapy: a 1-year experience
Source: Eur Respir J 2005; 26: Suppl. 49, 388s
Year: 2005

Predicting factors for the success of smoking cessation
Source: Eur Respir J 2005; 26: Suppl. 49, 389s
Year: 2005

Efficacy of bupropion therapy in smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 153s
Year: 2004

Factors affecting the success of smoking cessation treatment in a smoking cessation clinic
Source: International Congress 2017 – Smoking cessation
Year: 2017

Clinical and pathological determinants of abstinence rate in smoking cessation with varenicline
Source: Annual Congress 2010 - Smoking cessation interventions
Year: 2010

Success predicting factors in smoking cessation in asthma patients.
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019


Factors associated with abstinence and effectiveness of a smoking cessation program
Source: Eur Respir J 2006; 28: Suppl. 50, 390s
Year: 2006

Factors influencing dropout of a smoking cessation consultation in patients treated with varenicline
Source: Annual Congress 2012 - Act to change tobacco epidemics
Year: 2012

Abstinence rates and predictors of outcome for smoking cessation
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


Evaluation of prolonged bupropion treatment as an aid in smoking cessation
Source: Eur Respir J 2002; 20: Suppl. 38, 611s
Year: 2002

Improvement of quit smoking rate by combining varenicline and nicotine replacement therapy
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Exercise in addition to nicotine replacement therapy improves success rates in smoking cessation
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006


Bupropion together with cognitive-conductual therapy (CBT) is an alternative for a long-term abstinence of smoking
Source: Annual Congress 2013 –Smoking cessation for healthy and non-healthy smokers
Year: 2013


Smoking cessation success according to anxiety levels: experience of a smoking cessation program
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019

Smoking cessation with bupropion - is it successful enough?
Source: Eur Respir J 2005; 26: Suppl. 49, 388s
Year: 2005

Bupropion treatment and cognitive behavioural therapy in a smoking cessation program
Source: Eur Respir J 2001; 18: Suppl. 33, 12s
Year: 2001

Factors associated with relapse in smoking cessation
Source: Annual Congress 2012 - Tobacco cessation
Year: 2012